# RIVASTIGMINE TARTRATE
> **ANDA090879** · Abbreviated New Drug Application (Generic) · Sponsor: ORBION PHARMS · Approved 2015-06-10
## Drug
- **FDA Application Number:** ANDA090879
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIVASTIGMINE TARTRATE
- **Generic name:** Rivastigmine Tartrate
- **Active ingredients:** RIVASTIGMINE TARTRATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ORBION PHARMS
- **First approval:** 2015-06-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090879)
---
*MORVS · CC0 1.0*